RHOA and renal cell carcinoma: Additionally, given the critical roles of EphA2/FAK or RhoA signaling in malignant cellular behavior in various types of tumors, it is reasonable to investigate whether FAK or RhoA can act as a downstream effector of EphA2 in various RCC cell lines [12,16,17].